Neuroinflammation plays a key role in secondary brain damage after stroke. Although deleterious effects of proinflammatory cytokines are well characterized, direct cytotoxic effects of invading immune cells on the ischemic brain and the importance of their antigendependent activation are essentially unknown. Here we examined the effects of adaptive and innate immune cells-cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells-that share the direct perforin-mediated cytotoxic pathway on outcome after cerebral ischemia in mice. Although CTLs and NK cells both invaded the ischemic brain, only brain-infiltrating CTLs but not NK cells were more activated than their splenic counterparts. Depletion of CTLs decreased infarct volumes and behavioral deficit in two ischemia models, whereas NK cell depletion had no effect. Correspondingly, adoptive CTL transfer from wild-type into Rag1 knock-out mice increased infarct size. Adoptive CTL transfer from perforin knock-out or interferon-␥ knock-out mice into Rag1 knock-out mice revealed that CTL neurotoxicity was mediated by perforin. Accordingly, CTLs isolated from wild-type or interferon-␥ knock-out but not from perforin knock-out mice induced neuronal cell death in vitro. CTLs derived from ovalbumin-specific T-cell receptor transgenic mice were not activated and infiltrated less into the ischemic brain compared with wild-type CTLs. Their transfer did not increase the infarct size of Rag1 knock-out mice, indicating antigen-dependent activation as an essential component of CTL neurotoxicity. Our findings underscore the importance of antigen-dependent, direct cytotoxic immune responses in stroke and suggest modulation of CTLs and their effector pathways as a potential new strategy for stroke therapy.
Introduction
Ischemic cardiovascular disorders, including stroke, are the leading cause of death worldwide (Donnan et al., 2008) . Beyond early vascular recanalization (Donnan et al., 2008) , neuroinflammatory mechanisms are increasingly recognized as promising therapeutic targets in acute stroke (Iadecola and Anrather, 2011; Macrez et al., 2011; Chamorro et al., 2012) . However, the contribution of brain-invading innate and adaptive immune cell populations and their complex interplay with resident brain cells is only beginning to be understood. Recent studies suggested an important pathophysiological role of T cells in ischemia-induced secondary tissue damage of various organs, including the brain (Liesz et al., 2011; Chamorro et al., 2012) . Previous research on the mechanisms underlying neurotoxicity induced by T cells focused on the role of proinflammatory cytokines (Vila et al., 2000; Lambertsen et al., 2004; Schroeter and Jander, 2005; Yilmaz et al., 2006; Welsh et al., 2008) . In contrast, direct cell-cell interactiondependent cytolytic pathways, including the perforin-granzyme effector mechanism that plays an important role in microbial defense (Stenger et al., 1998) and primary autoimmune disorders (Kägi et al., 1997; Rieux-Laucat et al., 2005) , have received only little attention in the setting of ischemic diseases (Varda-Bloom et al., 2000; Zhang et al., 2008) . Cells of both the innate and the adaptive immune system-natural killer (NK) cells and cytotoxic CD8 ϩ T lymphocytes (CTLs), respectively-share these direct cytotoxic effector mechanisms (Sun and Lanier, 2011; Chamorro et al., 2012) . Although NK cells may participate in the pathogenesis of brain inflammation in multiple sclerosis (Kaur et al., 2013) , their role in post-ischemic neuroinflammation after stroke has barely been examined. NK cells are activated in an antigen-unspecific mode (Biron et al., 1999) , which makes them an ideal candidate for rapid cytotoxicity after stroke. In contrast, the canonical pathway of CTL activation and clonal expansion requires complex and time-consuming antigen-specific activation and the presence of costimulatory factors. Indeed, the mode of T-cell activation in the context of ischemia is currently viewed as a key enigma in the neuroimmunology of stroke (Iadecola and Anrather, 2011 ).
Here we characterize the different effects of CTLs and NK cells on the outcome after experimental murine stroke and reveal that differential activation of brain-invading immune cells determines their neurotoxic effect.
Materials and Methods
Mice. The study was conducted in accordance with national guidelines for the use of experimental animals. All experimental procedures were approved by the governmental committees (Animal Care Committee, Karlsruhe, Protocol 35, Germany) and were performed in accordance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines (Drummond et al., 2010) . Age-matched (10 -12 weeks old) mature male mice (C57BL/6J) were used for the experiments. Rag1 knock-out (Rag1 Ϫ/Ϫ ; The Jackson Laboratory) mice served as recipients for transfer experiments. As T-cell donors, we used wild-type (WT), perforin-1 knock-out (Prf1 Ϫ/Ϫ ; The Jackson Laboratory), interferon-␥ knock-out (IFN-␥ Ϫ/Ϫ ; The Jackson Laboratory), or Rag1 knock-out/ ovalbumin-specific T-cell receptor transgenic (OT-I; Taconic) mice. For two-photon microscopy experiments, we used neuronal yellow fluorescent protein-expressing mice (YFP-16; The Jackson Laboratory). All knock-out and transgenic animals were age-matched mature male mice on a C57BL/6 background. All mice were kept on a standard 12 h light/dark cycle and had access to food and water ad libitum.
In vivo depletion of CTLs and NK cells. We injected 300 g of cluster of differentiation 8␣ (CD8␣)-specific (clone 53-6.72; BioXCell) or 300 g of NK1.1-specific monoclonal antibody (clone PK136; BioXCell) or isotype antibody (IgG2, clone 2A3; BioXCell) diluted in sterile PBS intraperitoneally 24 h before, 5 h after, or 12 h after ischemia induction. We confirmed the depletion by flow cytometric analysis of leukocyte subpopulations isolated from blood and spleen. Animals were randomly allocated to treatment groups (isotype, anti-CD8, or anti-NK1.1 antibodies). Depletion was confirmed by the presence of Ͻ5% CD8 ϩ T cells in the CD3 ϩ cell population and Ͻ2% NKp46 ϩ cells among all leukocytes in blood 24 h to 7 d after ischemia.
Ischemia models. We induced permanent focal cerebral ischemia by transtemporal coagulation of the left middle cerebral artery (MCA) distal from the lenticulostriatal arteries as described previously (Zhou et al., 2013) . We used permanent MCA occlusion (pMCAO) model for all experiments unless stated otherwise. We induced transient focal ischemia by advancing a nylon monofilament to the left MCA for 30 min (tMCAO) as described previously (Zhou et al., 2013) . Experimental group sizes were determined based on a priori power analysis (G-power). We excluded animals in which surgery lasted for Ͼ25 min or that lost Ͼ 25% of their body weight during the 7 d observation period. Allocation of animals to treatment groups was randomized. Surgeons were blinded to treatment assignment.
Assessment of infarct volume. We determined the infarct volume on cresyl violet-stained cryosections. In brief, mice were deeply anesthetized with an intraperitoneal injection of ketamine/xylazine (100 and 10 mg/ kg, respectively) and transcardially perfused with cold saline. Brains were removed and immediately frozen, and 20-m-thick coronal cryosections were cut every 400 m and stained with cresyl violet. We scanned the stained sections at 600 dpi and measured the infarct areas using a public domain image analysis program (NIH ImageJ). The total infarct volume was obtained by integrating measured infarct areas and distance between sections. Correction for brain edema was applied by subtraction of the ipsilateral minus contralateral hemisphere volume from the directly measured infarct volume. Evaluators were blinded to treatment assignment.
Functional outcome tests. We performed the corner test (Zhang et al., 2002) 24 h before and 24 h, 3 d, and 7 d after pMCAO. The corner was formed by two boards each with a dimension of 30 ϫ 20 ϫ 1 cm attached at a 30°angle with a small opening along the joint to encourage the mouse entering the corner. After entering deep into the corner, the mouse rears forward and upward and then turns back to face the open end. We scored 12 turns for each test and calculated the percentage ratio of right turns of all turns and normalized on the performance before surgery of each individual mouse.
To assess neurological dysfunction in the tMCAO model, we evaluated the forelimb use asymmetry in the cylinder test (Li et al., 2004) . Briefly, mice were placed in a transparent glass cylinder (8 cm in diameter) and videotaped for 10 min. Contacts with the cylinder wall and landing with only one forelimb at the cylinder bottom as part of a full rear were scored using frame-by-frame playback (VLC Media Player). Ten independent forelimb contacts with the wall and 10 with the bottom of the cylinder were counted, and forelimb use asymmetry was expressed as a ratio of left-sided/all independent forelimb use. Evaluators were blinded to treatment assignment.
Immunohistochemistry. Neuronal loss was assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) method using a TUNEL apoptosis detection kit (Merck Millipore). Coronal cryostat sections (12 m) at the anterior commissure position were fixed in Ϫ20°C acetone for 5 min and then washed in PBS. Sections were then incubated with 10 mM sodium citrate buffer at 95-100°C for 10 min, followed by a TUNEL mixture for 60 min at 37°C. After washing and blocking, sections were incubated with avidin-FITC for 30 min at 37°C. For NeuN costaining, the sections were then blocked with 10% goat serum and incubated with rabbit polyclonal anti-NeuN (Abcam) overnight at 4°C. Cy3-conjugated goat anti-rabbit antibodies (Jackson ImmunoResearch) were applied on the sections for 1 h at room temperature. For analysis of cell numbers, we scanned the sections at 20ϫ magnification on a Leica TCS SP5 confocal microscope. We chose six regions with a size of 300 ϫ 300 m: two regions at the dorsal edge, two at the ventral edge of the infarcted [TUNEL-positive (TUNEL ϩ )] area, and 2 between at half distance. TUNEL ϩ and TUNEL-negative (TUNEL Ϫ ) neurons (NeuN ϩ cells) were counted. Nonspecifically stained structures were defined based on DAPI counterstaining and excluded from the analysis.
Preparation of cell suspensions. Mice were anesthetized and blood was drawn from the periorbital sinus into heparinized tubes. Leukocytes were isolated using a Ficoll-Hypaque gradient. We collected spleens after transcardial perfusion with saline. After homogenization and hypotonic lysis of red blood cells, we used the cell suspension for flow cytometric staining. For comparison of splenic and brain-invading leukocytes, spleens and the infarcted brain hemispheres were mechanically homogenized, and cell suspensions were incubated in dissociation buffer (10 ml of RPMI-1640, 180 U of collagenase IV, and 250 U DNase) for 20 min and overlaid on discontinuous Percoll gradients of 1.03 and 1.088 g/ml density. After gradient centrifugation, the collected mononuclear cells were used for flow cytometry or plated on 96-well plates.
In vitro restimulation. For investigation of in vitro function of CTLs and NK cells, we plated single-cell suspensions of 3 ϫ 10 5 mononuclear cells on 96-well plates (RPMI-1640 plus 10% FCS plus 2 mM glutamine plus 25 mM HEPES plus 1% penicillin/streptomycin plus 50 M ␤-mercaptoethanol). We processed each sample in duplicate. Cells were primed for 24 h with either plate-bound anti-mouse CD3 (BD Biosciences) to stimulate CTLs or plate-bound polyclonal goat anti-mouse NKp46 (R & D Systems) to stimulate NK cells or ovalbumin (SigmaAldrich) to stimulate CTLs from OT-I mice. Cells (except for the ovalbumin stimulation) were then restimulated for 5 h with ionomycin (BD Bioscience) and phorbol myristate acetate (Sigma-Aldrich) in the presence of protein transport inhibitor (BD Golgi Plug; BD Biosciences), followed by intracellular staining for IFN-␥.
Flow cytometric analysis. We stained the respective single-cell suspensions for anti-mouse CD3 (clone 17A2), CD4 (clone RM 4-5), CD8␣ (clone 3.155), B220 (RA3-6B2), NKp46 (clone 29A1.4), NK1.1 (PK136), Gr-1 (RB6-8C5), CD11b (clone M1/70), CD69 (clone H1.2F3), CD44 (IM7), CD62L (MEL-14), CD27 (clone LG.3A10), CD11c (clone HL3), Tbet (clone 4B10), Eomes (clone Dan11mag), IFN-␥ (clone XMG1.2), and the appropriate isotype control by following the protocols of the manufacturers (BD Biosciences, eBioscience). We performed flow cytometry on a BD Biosciences FACS Calibur, FACS Canto, and LSR II and analyzed the data by CellQuest Pro, FlowJo, and FACS Diva software, respectively. Gates were set according to unstained samples and isotype controls (BD Biosciences).
Real-time PCR. Ischemic and non-ischemic hemispheres were separately homogenized, and RNA was isolated with RNApure following the protocol of the manufacturer (Peqlab). We performed reverse transcription using the High Capacity cDNA Archive Kit (Applied Biosystems) and real-time PCR with SYBR-Green assays (Applied Biosystems) on a GeneAmp 5700 SDS from Applied Biosystems. All assays were run in duplicates. Primers for IFN-␥ and tumor necrosis factor-␣ (TNF-␣) were purchased as ready-to-use primer sets (Super Array). Results were normalized for each individual gene to the level of the housekeeping gene encoding peptidylprolyl isomerase A (cyclophilin), according to the relative standard curve method.
Cell sorting and adoptive cell transfer. We purified CD8 ϩ T cells by magnetic cell sorting (Miltenyi Biotec) from the spleens of WT, Prf1 Ϫ/Ϫ , IFN-␥ Ϫ/Ϫ , or OT-I mice. We injected intraperitoneally 6 ϫ 10 6 CD8 ϩ T cells into Rag1 Ϫ/Ϫ recipients. Rag1 Ϫ/Ϫ mice were randomly allocated to cell transfer groups (WT, Prf1
The purity of the CTLs used for cell transfer and the ratio of CTLs within the CD3 ϩ population of blood 2 weeks after cell transfer in Rag1 Ϫ/Ϫ mice were above 90% as analyzed by flow cytometry (data not shown).
In vitro coculture of neurons with CTLs. To investigate the neurotoxic effects of CTLs in vitro, the cortex was dissected from the brains of E16.5 mouse embryos, treated with 0.05% trypsin, and triturated with a firepolished glass pipette. Cells were then counted and resuspended in 10% serum-supplemented medium, and 2 ϫ 10 5 cells per well were plated on poly-L-lysine-coated coverslips on 24-well plates. Medium was replaced 24 h later with medium supplemented with N-2 and B-27 (Invitrogen), and neuronal culture was maintained for 7 d. The differentiated neurons were then incubated with 100 U/ml IFN-␥ overnight to upregulate their MHC class I expression (Neumann et al., 1995) . After washing steps, neurons were cocultured with CD8 ϩ T cells in a ratio of neurons to CD8 ϩ T cells of 2:1 or 10:1. We plated 2 ϫ 10 6 purified CD8 ϩ T cells isolated from the spleens of WT, Prf1 Ϫ/Ϫ , or IFN-␥ Ϫ/Ϫ mice on 24-well plates (RPMI-1640 plus 10% FCS plus 2 mM glutamine plus 25 mM HEPES plus 1% penicillin/streptomycin plus 50 M ␤-mercaptoethanol). Cells were primed for 48 h with plate-bound anti-mouse CD3 (BD Biosciences), 5 g/ml soluble CD28 (BD Biosciences), and 200 U/ml IL-2 (BD Biosciences). Activated CD8 ϩ T cells were then cocultured with neurons for 5 h, followed by immunofluorescent staining for neuronal apoptosis. Non-activated CD8 ϩ T cells isolated from WT mice were used as control for the coculture with neurons.
Immunocytochemistry. Adherent neurons on coverslips were fixed with 4% paraformaldehyde for 30 min and permeabilized with 0.5% Triton X-100 for 10 min, followed by blocking with 10% goat serum for 1 h. After incubation with mouse anti-microtubule-associated protein 2 (Map2; Sigma-Aldrich) and rabbit anti-caspase-3 (R & D Systems) in blocking buffer overnight at 4°C, cells were incubated with the appropriate fluorochrome-conjugated secondary antibodies: Cy2-conjugated goat anti-mouse (Jackson ImmunoResearch) and Cy3-conjugated goat anti-rabbit (Jackson ImmunoResearch) antibodies, respectively, for 1 h at room temperature. For analysis of neuronal apoptosis, 100 Map2 ϩ neurons were captured with 20ϫ magnification and classified as caspase-3 ϩ or caspase-3 Ϫ by two independent investigators from biological replicates. Nonspecifically stained structures were defined based on DAPI counterstaining and excluded from the analysis.
In vivo two-photon microscopy. We implanted a cranial window into 12-to 14-week-old YFP-16 mice. Mice were anesthetized with an intraperitoneal injection of ketamine/xylazine (100 and 10 mg/kg, respectively). We performed a craniectomy with subsequent removal of the dura mater. We covered the brain surface with physiologic sodium chloride solution and glued a round cover glass (6 mm diameter) to the skull with dental acrylic glue. Three weeks later, we induced pMCAO by transtemporal coagulation of the left MCA lateral from the cranial window. For fluorescent labeling, 2 ϫ 10 6 /ml CD8 ϩ T cells purified by magnetic cell sorting were incubated with 25 g/ml CMTPX (red fluorescent dye) for 30 min at 37°C. Immediately after MCAO, we injected 6 ϫ 10 6 CMTPX-labeled CD8 ϩ T cells intravenously. We used a Coherent Chameleon Ultra II Laser (690 -1064 nm; Coherent) equipped with a twophoton microscope (LSM 7 MP; Zeiss) for in vivo multiphoton laser scanning microscopy. A custom-made microscopy stage was used for fixation of the cranium. We used a mixture of O 2 and 1-2% isoflurane for anesthesia and kept the body temperature of mice constant by using a heating pad. Images were acquired at an excitation wavelength of 850 nm. Laser power was limited to a minimum, not exceeding 5-7% of total power at the surface, and 50% in 350 mm depth. At this power, no phototoxic damage to brain tissue was detectable over the time course of investigations. Pictures and videos were taken daily from day 3 until day 7 after MCAO through the cranial window above the ischemic hemisphere. 
Results

CD8
؉ T cells but not NK1.1 ؉ cells worsen outcome after stroke We investigated the effect of CTLs and NK1.1 ϩ cells on neurological outcome after focal brain ischemia in mice by in vivo depletion of the respective cell populations using monoclonal antibodies against CD8␣ (Ly-2) or NK1.1 (PK136). Antibody administration resulted in 85% depletion of CD8 ϩ cells and 90% depletion of NK cells in blood (Fig. 1 A, B) . Both cell populations were diminished during the 7 d observation period, whereas other leukocyte populations were not affected by the treatment (data not shown). For the evaluation of the effect of CTLs on infarct size 14 d after pMCAO, CD8 ϩ T-cell depletion was also verified at this later time point.
We used two experimental paradigms of brain ischemia to test the effect of selective cell depletion: transcranial pMCAO inducing cortical infarcts and 30 min tMCAO resulting in striatal lesions (Fig. 1C) . Between 12 h and 3 d after pMCAO, infarct sizes of control and anti-CD8␣-treated animals did not differ significantly (Fig. 1D) , whereas at days 7 and 14, CTL depletion significantly reduced infarct volumes compared with isotype-treated controls ( p ϭ 0.012 and p ϭ 0.009, respectively). Moreover, injection of CD8␣-specific antibodies also reduced infarct size when administered 5 h after MCAO induction and tended to reduce infarct volume when given 12 h after stroke onset (Fig.  1D) , underlining the therapeutic potential. To assess the func- tional neurological deficit resulting from pMCAO, we performed the corner test 24 h, 3 d, 7 d, and 14 d after ischemia onset (Fig.  1E) . In both control and anti-CD8␣-treated groups, MCAO induced an increase in right turns at day 3, indicating behavioral asymmetry. By 7 d after pMCAO, this asymmetry was significantly improved in the anti-CD8␣-treated mice compared with controls. By day 14, we observed an improvement of neurologic function in both control and anti-CD8␣-treated groups. Similarly to the pMCAO model, CTL depletion significantly reduced infarct volumes 7 d after tMCAO ( p ϭ 0.041). This effect was accompanied by improvement in motor function assessed in the cylinder test (Fig. 1F) . Consistent with the effect of antibodymediated depletion, adoptively transferred CD8 ϩ T cells increased the infarct volume of lymphocyte-deficient Rag1 Ϫ/Ϫ mice compared with Rag1 Ϫ/Ϫ mice without cell transfer (see also below). We then investigated the effect of NK1.1-specific depleting antibody on stroke outcome also in both experimental paradigms. In contrast to anti-CD8␣-treated animals, we detected no difference in infarct size between anti-NK1.1-treated and control animals 7 d after ischemia in either the pMCAO or tMCAO model (Fig. 1G) . Moreover, sensorimotor dysfunction was not improved by treatment with NK1.1-specific antibodies (Fig. 1H ) .
The reduction of infarct size in CTL-depleted animals is a result of neuroprotection
The early edema formation and the following shrinkage of the infarct size are well known phenomena of rodent stroke models (Henrich-Noack et al., 2008) , complicating the interpretation of results with neuroprotective agents . We observed an effect of CTL depletion on infarct size first at 7 d after MCAO in which infarcts were already compacted compared with earlier time points. This raises the question of whether CTL depletion resulted in infarct size reduction as a result of neuroprotection or accelerated removal of the infarcted tissue. To answer this question, we performed NeuN-TUNEL costaining 1, 3, and 7 d after pMCAO ( Fig. 2A) and analyzed the ratio of intact neurons among all neurons (NeuN ϩ TUNEL Ϫ /NeuN ϩ ) in six regions of the infarcted area (Fig. 2B) . After the initial neuronal death resulting from cerebral ischemia, we found additional intense neuronal loss between days 1 and 7 that was most prominent in the dorsal regions of the infarct (Fig. 2B) . In this area, CTL depletion prevented neuronal loss 7 d after MCAO and resulted in similar ratios of TUNEL Ϫ neurons as seen 1 d after stroke (Fig. 2C,D) . Our findings suggest that the reduced infarct size observed in CTLdepleted mice resulted from neuroprotection. However, an influence of CTLs on removal of the infarcted brain tissue cannot be ruled out.
NK cells are more abundant than CTLs in the brain after stroke
We isolated brain-invading leukocytes from the ischemic hemispheres of isotype antibody-, anti-CD8␣-, and anti-NK1.1-treated mice 3 and 7 d after pMCAO and analyzed leukocyte subsets by flow cytometry (Fig. 3A) . The majority of leukocytes in the brain homogenates were microglia/ monocytes and granulocytes 7 d after pMCAO (Fig. 3B) . Their number and B-cell counts were altered by neither of the antibody treatments (data not shown). In isotype-treated mice, the number of both CTLs and NK cells increased between 3 and 7 d after MCAO. Approximately threefold higher cell counts of NK cells than CTLs (n ϭ 5, p ϭ 0.0013) were detected in the ischemic hemisphere 7 d after MCAO (Fig. 3C,D) . CD8 ϩ and NK1.1 ϩ cell depletion resulted in significantly reduced numbers of the respective cell population at both time points. Interestingly, NK1.1 ϩ cell depletion resulted in an increased number of brain-invading CTLs compared with control animals 7 d after ischemia onset.
For a better understanding of the delayed effect on infarct volume and relative long therapeutic time window of CTL depletion, we characterized the kinetics of CTL invasion into the brain by flow cytometry (Fig. 3E) . No significant CTL infiltration was detectable 12 h after stroke, the number of CTLs increased between days 1 and 3, whereas the majority of CTLs invaded between days 3 and 7 (Fig. 3E ).
Brain-invading CTLs but not NK cells are activated
To investigate the cause of their different effects in the ischemic brain, we examined the activation state of splenic and braininvading CTLs and NK cells 7 d after MCAO (Fig. 4 A, B) . Activation of CTLs was determined by the surface expression of CD69, CD44, and CD62L molecules. Brain-invading CTLs were more activated compared to splenic CTLs from either sham-operated or ischemic mice (Fig.  4 A, C) . In contrast, there was no difference between splenic and brain-invading NK cells in the expression of surface markers B220, NKp46, or CD11c (Fig.  4 B, D) . Correspondingly, expression of effector function-associated transcription factors, such as Tbet and Eomes (Fig. 4E) , did not differ between splenic and braininvading NK cells. We further investigated the functional activation state of splenic and brain-derived CTL and NK cells isolated 7 d after MCAO by in vitro stimulation and subsequent analysis of IFN-␥ expression. Both splenic and braininvading CTLs responded with IFN-␥ production during in vitro stimulation (Fig. 4F ) . In contrast, only splenic NK cells showed IFN-␥ production, suggesting an inactive functional status of braininvading NK cells. 
The deleterious effect of CTL is mediated via perforin
In subsequent experiments, we focused on the role of CTLs in cerebral ischemia. To investigate perforin secretion as the potential effector mechanism responsible for the deleterious effect of CTLs, we performed adoptive CTL transfer from WT or Prf1
Ϫ/Ϫ mice. IFN-␥ production of CTLs isolated from Prf1 Ϫ/Ϫ mice was fully intact as shown by in vitro stimulation assays (data not shown). Seven days after Ϫ/Ϫ mice receiving 6 ϫ 10 6 CD8 ϩ T cells from WT or Prf1 Ϫ/Ϫ mice (n ϭ 9 per group; *p Ͻ 0.05). Whiskers show the 5th to 95th percentiles. B, Relative expression (RE) of TNF-␣ and IFN-␥ mRNA in the ischemic and non-ischemic hemispheres of Rag1 Ϫ/Ϫ mice with or without cell transfer from WT orPrf1 Ϫ/Ϫ donors7dafterMCAO(nϭ5pergroup;*pϽ0.05).DataareexpressedasmeanϮSD.C,InfarctvolumeofRag1 Ϫ/Ϫ micereceiving6ϫ10 6 CD8 ϩ TcellsfromIFN-␥ Ϫ/Ϫ mice(nϭ9pergroup; *pϽ0.05).Whiskersshowthe5thto95thpercentiles.D,RepresentativeimageofMap2-CD8costainingofembryoniccorticalneuronalculture7dafterdissectionfromE16.5mouseembryos.Scalebar,20m. E,RepresentativeimagesofMap2-caspase-3(Casp-3)costainingofcoculturesofneuronswithnon-activated(NonactCTL)oractivatedCD8
ϩ TcellsisolatedfromWTmice(WTaCTL)oractivatedCD8 ϩ Tcells isolatedfromperforinknock-out(Prf1 Ϫ/Ϫ aCTL)orfromIFN-␥knock-out(INF-␥ Ϫ/Ϫ aCTL)miceinaratioofneuronstoCTL2:1.Scalebar,20m.F,SemiquantitativeanalysisofCasp-3 ϩ neuronsincoculture with non-activated or activated CTLs isolated from WT mice or with activated CTLs isolated from Prf1 Ϫ/Ϫ or INF-␥ Ϫ/Ϫ mice in a ratio of neurons to CTL 2:1 (top) or 10:1 (bottom).
MCAO, the mean infarct size of untreated Rag1 Ϫ/Ϫ mice was ϳ50% smaller compared with WT animals. Adoptive transfer of 6 ϫ 10 6 CTLs from WT mice significantly increased infarct volume (Fig. 5A) . In contrast, the infarct size of mice receiving CD8 ϩ T cells from Prf1 Ϫ/Ϫ mice did not differ from untreated Rag1 Ϫ/Ϫ animals. Proinflammatory cytokines, such as INF-␥, are crucial effector molecules in CTL-induced cytotoxicity in models of infectious diseases (Slifka and Whitton, 2000) . Therefore, we explored the potential role of proinflammatory cytokines in CTL-induced neurotoxicity. Cerebral expression of TNF-␣ and IFN-␥ in ischemic and non-ischemic hemispheres of Rag1 Ϫ/Ϫ mice receiving adoptive CTL cell transfer from WT or Prf1 Ϫ/Ϫ mice did not differ significantly 7 d after pMCAO (Fig. 5B) . Moreover, adoptive transfer of CTL transfer from IFN-␥ Ϫ/Ϫ into Rag1 Ϫ/Ϫ mice significantly increased the infarct size of Rag1 Ϫ/Ϫ mice (Fig. 5C ). This suggested rather a minor role of proinflammatory cytokines compared with the perforin pathway in CTL-induced neuronal death after stroke.
We further investigated CTL-mediated neurotoxicity in vitro using coculture of embryonic cortical neurons and CTLs (Fig.  5D ). To simulate post-stroke upregulation of cerebral IFN-␥ expression (Yilmaz et al., 2006; Liesz et al., 2011) , differentiated neurons were incubated with IFN-␥. This increases MHC class I expression on neurons (Neumann et al., 1995) and makes them a potential target for CTLs (Chevalier et al., 2011) . Coculture of neurons with non-activated CTLs did not increase neuronal death as measured by caspase-3 staining (Fig. 5 E, F ) . In contrast, activated CTL induced apoptosis in 75.2 and 37.8% of neuronal cells when cocultured in ratios of neurons to CTL of 2:1 and 10:1, respectively. Coculture with activated CTL derived from IFN-␥-deficient mice led to a similar proportion of neuronal cell death as from WT mice. In contrast, activated CD8 ϩ T cells from Prf1 Ϫ/Ϫ mice did not increase the ratio of apoptotic neurons (Fig. 5 E, F ) . Altogether, these in vitro observations further support our in vivo findings regarding the importance of the perforin pathway in CTL-induced neurotoxicity.
To illustrate the interaction between neurons and CTLs suggested by the perforin dependency of CTL-induced neuronal death, we performed in vivo brain imaging by two-photon microscopy after pMCAO (Fig. 6A) focusing on the peri-infarct area. We observed CTLs that appeared to be attached to the vessel wall 3 d after ischemia onset (Fig. 6B) . Later, an increasing number of CTLs infiltrated into the brain parenchyma (Fig. 6C) . On day 5, some CTLs were in close proximity to neurons, which were no longer detectable on day 7 (Fig. 6D) .
CTLs require antigen-dependent activation
To analyze whether antigen recognition is required for the activation and the neurotoxic effect of CTLs, we used Rag1 knockout/OT-I transgenic mice that express exclusively a T-cell receptor (TCR) directed against chicken ovalbumin, an antigen not present in mice. CTLs derived from these mice were functionally competent according to their response to in vitro stimulation with anti-CD3 and ovalbumin (data not shown). Consistent with the previous transfer experiment (Fig. 5A) , adoptive transfer of CTLs from WT mice into Rag1 Ϫ/Ϫ mice significantly increased infarct volume 7 d after pMCAO. In contrast, CTL transfer from OT-I animals did not alter stroke outcome (Fig. 7A) , indicating the need for antigen-dependent TCR activation for the neurotoxic effector function of CTL.
We further investigated antigen-dependent recruitment of CTLs to the ischemic brain and the activation status of braininvading CTLs using the adoptive cell-transfer paradigm. CTLs isolated from WT, Prf1 Ϫ/Ϫ , or OT-I donor animals were transferred into Rag1 Ϫ/Ϫ mice. Post-ischemic CTL cell number and activation state of cells from brain were compared with WT animals. The number of brain-invading CTLs in Rag1 Ϫ/Ϫ animals receiving cell transfer from WT and Prf1 Ϫ/Ϫ animals was similar to WT mice. In contrast, significantly less ovalbumin-specific CTLs entered the ischemic brain (Fig. 7B) .
We analyzed the activation state of brain-invading CD8 ϩ T cells by CD44 and CD69L expression. The activation state of brain-invading CTLs in WT mice and in Rag1 Ϫ/Ϫ mice receiving cell transfer from WT or Prf1 Ϫ/Ϫ animals was similar, whereas brain-invading ovalbumin-specific CTLs were significantly less activated (Fig. 7C,D) . Together, these results suggest an important role of TCR-dependent mechanisms for CTL activation and migration into the ischemic brain.
Discussion
The major findings of our study are that (1) CTLs have delayed deleterious effects after acute cerebral ischemia, (2) they require antigen-dependent activation, and (3) perforin secretion is their main effector mechanism. (4) Despite the similar effector repertoire of NK cells, their depletion did not affect neurological outcome after murine stroke.
The effect of CTLs and the lacking effect of NK cells on stroke outcome was shown in two experimental models (pMCAO vs tMCAO), and neurological deficit paralleled histological outcome. Furthermore, we used two experimental paradigms of CTL elimination (antibody-mediated depletion and selective adoptive cell transfer into lymphocyte-deficient mice) that consistently suggested a deleterious effect of CTLs. Thus, our findings unequivocally support the concept of perforin-mediated neurotoxicity of CTLs after brain ischemia, and a therapeutic window of at least 5 h after ischemia onset suggests potential clinical relevance.
NK cells belong to the "first line of defense" (Lodoen and Lanier, 2006), which can be activated by danger-associated molecules (Elsner et al., 2010) . Thus, in theory, NK cells appeared as better candidates for post-ischemic inflammatory brain damage than CTLs. Compared with other immune cells that migrate to the brain within hours after ischemic damage, the post-ischemic brain invasion of T cells occurred with a considerable delay in the present and previous studies (Gelderblom et al., 2009; Liesz et al., 2011; Zhou et al., 2013) . Indeed, NK cells outnumbered CTLs approximately threefold in the ischemic brain. However, the activation and functional state of both leukocyte subpopulations differed substantially. We discovered enhanced activation of brain-infiltrating CTLs as revealed by upregulation of CD69 and CD44 and downregulation of CD62L (Caruso et al., 1997; Chao et al., 1997; DeGrendele et al., 1997) . In contrast, no difference was found between the activation state of splenic and braininvading NK cells based on the cell surface expression of B220, CD11c (Vosshenrich et al., 2007) , and NKp46 (Sivori et al., 1997) . Similarly, transcription factors, such as Tbet and Eomes, that regulate NK cell effector functions (Gordon et al., 2012) did not differ between brain-invading and splenic NK cells. Moreover, CTLs but not NK cells derived from the ischemic brain responded with IFN-␥ production to in vitro stimulation. Together, CTLs but not NK cells are activated and only CTLs harm the ischemic brain. The absence of an effect of NK cells on stroke outcome in our experiments contrasts a recent report suggesting a deleterious role of NK cells in ischemia (Gan et al., 2014) . This study used an ischemia model that causes large brain infarcts, a wasting syndrome, severe systemic immune depression (Liesz et al., 2009; Meisel and Meisel, 2011) , and less inflammatory brain , or OT-I donor animals (n ϭ 5 per group; *p Ͻ 0.05).
invasion (Zhou et al., 2013) than the models used in our study. Nevertheless, this discrepancy may potentially point to heterogeneous-beneficial and deleterious-roles of different NK cell subpopulations. Despite increasing the number of infiltrating CTLs in our study, depletion of NK1.1 ϩ cells did not worsen neurological outcome. NK cell-mediated suppressor effects were described in experimental allergic encephalomyelitis (Zhang et al., 1997; Xu et al., 2005) . Therefore, the effect of distinct subpopulations of NK cells in different forms of cerebral ischemia deserves additional attention. CD8 ϩ T cells may play deleterious roles either through contact-dependent direct cytotoxicity or via humoral pathways, including the release of IFN-␥ (Harty et al., 2000) . Neither the transfer of purified CD8 ϩ T cells into Rag1 Ϫ/Ϫ mice affected cerebral expression of proinflammatory cytokines such as IFN-␥, nor did the lack of IFN-␥ attenuated CTL-induced neurotoxicity in vivo or in vitro. This suggested a more important role of direct cytotoxicity in ischemia for CTL-mediated neuronal damage. The direct cytotoxic effect of CTL can be mediated via two independent pathways: (1) the release of cytotoxic granules containing perforin and granzymes; or (2) via receptor/ligand interaction between Fas receptor on the target cell and Fas ligand (FasL) on CTLs (Kägi et al., 1996) . We focused on the perforin pathway because our previous experiments in perforin-deficient mouse strains supported the importance of perforin-mediated cytotoxicity in post-ischemic brain damage (Liesz et al., 2011) . Moreover, murine neurons are resistant to FasL-mediated killing but are highly sensitive to cytotoxic granules in vitro (Rensing-Ehl et al., 1996) . Although Prf1 Ϫ/Ϫ CD8 ϩ T cells were activated and infiltrated the ischemic brain, they failed to increase infarct volume. Moreover, CD8
ϩ T cells isolated from Prf1 Ϫ/Ϫ mice did not show neurotoxic effects in vitro, consistent with a crucial role of the perforin-dependent neurotoxic effect of CTLs. We found CTLs in close vicinity to some of the degenerating neurons using in vivo two-photon microscopy compatible with a cell-cell contact-dependent cytolytic activity. However, the exact mechanisms of cellular interaction have to be elucidated further.
The involvement of antigen-dependent activation and clonal expansion of T cells in post-ischemic neuroinflammation is an important unresolved issue of stroke immunology (Iadecola and Anrather, 2011) . In the present study, adoptive transfer of CTLs expressing ovalbumin-specific TCR resulted in impaired cell activation, reduced CTL brain invasion, and smaller infarct volumes 7 d after stroke. Early detrimental effects of T cells appeared to be independent of antigen recognition (Kleinschnitz et al., 2010) . Our results indicate the requirement of antigen-dependent CTL activation for their delayed neurotoxic effects. Additional studies will be needed to address the distinct pathways and involved antigens for CTL activation.
In conclusion, our study provides important new insights into the mechanisms of direct cytotoxicity in immune-mediated ischemic brain damage. Only antigen dependently activated CTLs exert a profound delayed neurotoxic effect via the perforin pathway, whereas NK cells do not affect outcome. CTL depletion by specific antibodies or neutralization of their effector mechanism are potential targets for stroke therapy.
